Phosphorylation of SMAD3 in immune cells predicts survival of patients with early stage non-small cell lung cancer

Sebastian Marwitz(Research Center Borstel - Leibniz Lung Center), Bernard A. Fox(Oregon Health & Science University)
Journal for ImmunoTherapy of Cancer
February 1, 2021
Cited by 26


Related Papers